BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sexton RE, Hallak MNA, Uddin MH, Diab M, Azmi AS. Gastric Cancer Heterogeneity and Clinical Outcomes. Technol Cancer Res Treat 2020;19:1533033820935477. [PMID: 32799763 DOI: 10.1177/1533033820935477] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Sremac M, Paic F, Grubelic Ravic K, Serman L, Pavicic Dujmovic A, Brcic I, Krznaric Z, Nikuseva Martic T. Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma. Oncol Lett 2021;22:822. [PMID: 34691249 DOI: 10.3892/ol.2021.13083] [Reference Citation Analysis]
2 Baharudin R, Ishak M, Muhamad Yusof A, Saidin S, Syafruddin SE, Wan Mohamad Nazarie WF, Lee L, Ab Mutalib N. Epigenome-Wide DNA Methylation Profiling in Colorectal Cancer and Normal Adjacent Colon Using Infinium Human Methylation 450K. Diagnostics 2022;12:198. [DOI: 10.3390/diagnostics12010198] [Reference Citation Analysis]
3 Hempel L, de Oliveira JV, Gaumann A, Milani V, Schweneker K, Schenck K, Fleischmann B, Philipp P, Mederle S, Garg A, Piehler A, Gandorfer B, Schick C, Kleespies A, Sellmann L, Bartels M, Goetze TO, Stein A, Goekkurt E, Pfitzner L, Robert S, Hempel D. Landscape of Biomarkers and Actionable Gene Alterations in Adenocarcinoma of GEJ and Stomach-A Real World Data Analysis. Cancers (Basel) 2021;13:4453. [PMID: 34503263 DOI: 10.3390/cancers13174453] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chen X, Chen Y, Li T, Jun L, Lin T, Hu Y, Huang H, Chen H, Liu H, Li T, Li G, Yu J. Impact of diabetes on prognosis of gastric cancer patients performed with gastrectomy. Chin J Cancer Res 2020;32:631-44. [PMID: 33223758 DOI: 10.21147/j.issn.1000-9604.2020.05.08] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Chaithongyot S, Jantaree P, Sokolova O, Naumann M. NF-κB in Gastric Cancer Development and Therapy. Biomedicines 2021;9:870. [PMID: 34440074 DOI: 10.3390/biomedicines9080870] [Reference Citation Analysis]
6 Perez M, Chakraborty A, Lau LS, Mohammed NBB, Dimitroff CJ. Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target. Br J Dermatol 2021;185:294-301. [PMID: 33660254 DOI: 10.1111/bjd.19891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]